Data Entry Maintenance

Metadata Commons Identifier

HMC000096

Project Title

BQC19: Biobanque québécoise de la COVID-19

Project Description

<p>The <a href="https://www.quebeccovidbiobank.ca/">“Biobanque québécoise de la COVID-19” (BQC19)</a> is a pan–provincial initiative undertaken in Québec, Canada to enable the collection, storage and sharing of samples and data related to the COVID-19 crisis. As a disease-oriented biobank based on high-quality biosamples and clinical data of hospitalized and non-hospitalized SARS-CoV-2 PCR positive and negative individuals. The BQC19 follows a legal and ethical management framework approved by local health authorities. The biosamples include plasma, serum, peripheral blood mononuclear cells and DNA and RNA isolated from whole blood. In addition to the clinical variables, BQC19 will provide in-depth analytical data derived from the biosamples including whole genome and transcriptome sequencing, proteome and metabolome analyses, immunoserology analysis with multiplex measurements of key circulating markers as well as anti-SARS-CoV-2 antibody responses.</p>

Project Funder(s)

FRQS (Fonds de Recherche du Quebec-Sante), Genome Quebec, Public Health Agency of Canada, Quebec's Ministry of Health and Social Services

Project Institution(s)

McGill, University of Montreal Hospital Center (CHUM)

Project Investigator(s)

Simon Rousseau, Madeleine Durand

Data Access Request URL*

https://bqc19.bento.sd4h.ca/en/

Keywords

COVID-19, biobank, multiomics, longitudinal study

Publication Link

https://pubmed.ncbi.nlm.nih.gov/34010280/

Study Completed

Cohort Name

BQC19

Cohort Size

6272

Disease/Condition Studied

severe COVID-19, non-severe COVID-19, long COVID, critical COVID-19, COVID-19

Enrollment Time Window

2020-2024

Biobanking Consent Available

Medical History Available

Ethnicity Availability

Time Course

Patient Phenotypes

Participants who underwent a PCR test for SARS-CoV-2 with either a positive or negative result

Patient Outcomes

Severity of the disease, Long-COVID. Please refer to https://bqc19.bento.sd4h.ca/en/search for more outcomes

Clinical Data Types Available

Demographics, hospitalization, symptoms, comorbidities, medication, vital signs, lab results, oxygen therapy, vaccination, long-COVID questionnaire

Time Course Data Points

Hospitalized: 0, 2, 7, 14 and 30 days post infection; Outpatients&Hospitalized: 3, 6, 12, 18 and 24 months post infection

Enrollment City

Groups

Project

Cohort

Enrollment City

Groups

Samples and Omics